Paper32437331
Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease.
Shrestha B and 14 others. J Clin Invest, 2020. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease. Papers, record 32437331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32437331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adoptive Transfer | Major topic |
| Antigens, CD | Major topic |
| CD4-Positive T-Lymphocytes | Major topic |
| Graft vs Host Disease | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Immunoglobulins | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Membrane Glycoproteins | Major topic |
| Neoplasm Proteins | Major topic |
| Receptors, Chimeric Antigen | Major topic |
| Allografts | |
| Animals | |
| Cell Line, Tumor | |
| Humans | |
| Mice | |
| CD83 Antigen |
Source PubMed
Grants13
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 HL133823 | NHLBI NIH HHS | United States | R01HL133823 | PubMed and NIH | NIH RePORTER |
| P30 CA077598 | NCI NIH HHS | United States | P30CA077598 | PubMed and NIH | NIH RePORTER |
| R01 HL118979 | NHLBI NIH HHS | United States | R01HL118979 | PubMed and NIH | NIH RePORTER |
| R01 HL126530 | NHLBI NIH HHS | United States | R01HL126530 | PubMed | NIH RePORTER |
| R01 HL147324 | NHLBI NIH HHS | United States | R01HL147324 | PubMed | NIH RePORTER |
| R37 AI034495 | NIAID NIH HHS | United States | R37AI034495 | PubMed and NIH | NIH RePORTER |
| P30 CA076292 | NCI NIH HHS | United States | P30CA076292 | PubMed and NIH | NIH RePORTER |
| R01 HL155114 | NHLBI NIH HHS | United States | R01HL155114 | PubMed | NIH RePORTER |
| R01 HL056067 | NHLBI NIH HHS | United States | R01HL056067 | PubMed and NIH | NIH RePORTER |
| K08 HL116547 | NHLBI NIH HHS | United States | K08HL116547 | PubMed and NIH | NIH RePORTER |
| P01 CA142106 | NCI NIH HHS | United States | P01CA142106 | PubMed | NIH RePORTER |
| K12 CA090625 | NCI NIH HHS | United States | K12CA090625 | PubMed | NIH RePORTER |
| P01 CA065493 | NCI NIH HHS | United States | P01CA065493 | PubMed and NIH | NIH RePORTER |
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30574153 | Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity. | Front Immunol | 2018 | https://conductscience.org/library/papers/30574153 | PubMed |
| 2 | 11748282 | The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. | J Exp Med | 2001 | https://conductscience.org/library/papers/11748282 | PubMed |
| 3 | 11896281 | Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. | Science | 2002 | https://conductscience.org/library/papers/11896281 | PubMed |
| 4 | 28416503 | Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cells. | Blood | 2017 | https://conductscience.org/library/papers/28416503 | PubMed |
| 5 | 82837 | Cyclosporin A for the treatment of graft-versus-host disease in man. | Lancet | 1978 | https://conductscience.org/library/papers/82837 | PubMed |
| 6 | 19804837 | T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease. | Biol Blood Marrow Transplant | 2010 | https://conductscience.org/library/papers/19804837 | PubMed |
| 7 | 29385370 | Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29385370 | PubMed |
| 8 | 28067900 | Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity. | Nat Med | 2017 | https://conductscience.org/library/papers/28067900 | PubMed |
| 9 | 20952687 | Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. | Blood | 2011 | https://conductscience.org/library/papers/20952687 | PubMed |
| 10 | 20807889 | Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. | Blood | 2010 | https://conductscience.org/library/papers/20807889 | PubMed |
| 11 | 31811055 | T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage. | Sci Immunol | 2019 | https://conductscience.org/library/papers/31811055 | PubMed |
| 12 | 24553386 | Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. | Sci Transl Med | 2014 | https://conductscience.org/library/papers/24553386 | PubMed |
| 13 | 23851696 | Topical application of soluble CD83 induces IDO-mediated immune modulation, increases Foxp3+ T cells, and prolongs allogeneic corneal graft survival. | J Immunol | 2013 | https://conductscience.org/library/papers/23851696 | PubMed |
| 14 | 29875316 | CD83 expression is essential for Treg cell differentiation and stability. | JCI Insight | 2018 | https://conductscience.org/library/papers/29875316 | PubMed |
| 15 | 29382747 | Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/29382747 | PubMed |
| 16 | 30479692 | Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution. | Oncotarget | 2018 | https://conductscience.org/library/papers/30479692 | PubMed |
| 17 | 23908471 | Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease. | Blood | 2013 | https://conductscience.org/library/papers/23908471 | PubMed |
| 18 | 24982504 | Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. | Blood | 2014 | https://conductscience.org/library/papers/24982504 | PubMed |
| 19 | 28375154 | Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. | J Clin Invest | 2017 | https://conductscience.org/library/papers/28375154 | PubMed |
| 20 | 26563133 | Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect. | Blood | 2016 | https://conductscience.org/library/papers/26563133 | PubMed |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42933888 | CD83 CAR T provides an alternative strategy to CD19-targeting in B cell malignancies. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42933888 | PubMed |
| 42755912 | Progress in reprogramming failed graft-versus-leukemia immunity in acute myeloid leukemia relapse after allogeneic transplantation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42755912 | PubMed |
| 42575882 | CAR T cell therapy beyond cancer: current status, challenges and future prospects. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42575882 | PubMed |
| 42159047 | Current Status of Treg Therapy in Transplantation and Autoimmune Disease. | Immunology | 2026 | https://conductscience.org/library/papers/42159047 | PubMed |
| 42084784 | Advances in Cell Therapy for Chronic Graft-versus-Host Disease: Prophylactic and Therapeutic Perspectives. | Clin Exp Med | 2026 | https://conductscience.org/library/papers/42084784 | PubMed |
| 41721623 | Nanobody-Engineered CLL-1 CAR T Cells: Optimizing Tumor-Specific Cytotoxicity and Minimizing Off-Tumor Toxicity. | Cancer Res Commun | 2026 | https://conductscience.org/library/papers/41721623 | PubMed |
| 41172558 | Regulatory T cell approaches for graft-versus-host disease prevention. | Curr Opin Immunol | 2026 | https://conductscience.org/library/papers/41172558 | PubMed |
| 40206475 | Cell therapies for immune-mediated disorders. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40206475 | PubMed |
| 40117296 | Cellular therapies for the prevention and treatment of acute graft-versus-host disease. | Stem Cells | 2025 | https://conductscience.org/library/papers/40117296 | PubMed |
| 40117019 | Tonic signaling in CAR-T therapy: the lever long enough to move the planet. | Front Med | 2025 | https://conductscience.org/library/papers/40117019 | PubMed |
| 39915926 | Chronic Graft-versus-host Disease, Part 2: Clinical Success and Roadmap to the Future. | Transplantation | 2025 | https://conductscience.org/library/papers/39915926 | PubMed |
| 39451198 | Mini-Review: Tregs as a Tool for Therapy-Obvious and Non-Obvious Challenges and Solutions. | Cells | 2024 | https://conductscience.org/library/papers/39451198 | PubMed |
| 39242117 | Immune isolation-enabled nanoencapsulation of donor T cells: a promising strategy for mitigating GVHD and treating AML in preclinical models. | J Immunother Cancer | 2024 | https://conductscience.org/library/papers/39242117 | PubMed |
| 39113144 | Multi-omics analysis reveals a feedback loop amplifying immune responses in acute graft-versus-host disease due to imbalanced gut microbiota and bile acid metabolism. | J Transl Med | 2024 | https://conductscience.org/library/papers/39113144 | PubMed |
| 38986621 | Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity. | Cell Rep Med | 2024 | https://conductscience.org/library/papers/38986621 | PubMed |
| 38702309 | Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression. | Nat Commun | 2024 | https://conductscience.org/library/papers/38702309 | PubMed |
| 38659486 | Cellular strategies to induce immune tolerance after liver transplantation: Clinical perspectives. | World J Gastroenterol | 2024 | https://conductscience.org/library/papers/38659486 | PubMed |
| 38618950 | Major breakthroughs in hematopoietic stem cell transplantation and future challenges in clinical implementation. | J Clin Invest | 2024 | https://conductscience.org/library/papers/38618950 | PubMed |
| 38283344 | Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation. | Front Immunol | 2023 | https://conductscience.org/library/papers/38283344 | PubMed |
| 37958378 | Epigenetic Profiling of PTPN11 Mutant JMML Hematopoietic Stem and Progenitor Cells Reveals an Aberrant Histone Landscape. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37958378 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD83 | 9308 | PubTator's text mining | https://conductscience.org/library/genes/9308 | NCBI Gene |
| NR1I3 | 9970 | PubTator's text mining | https://conductscience.org/library/genes/9970 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32437331
GET https://conductscience.org/api/papers/v1/32437331/references?page=2